-
Solara Labs launches BariMelts line of supplements for Bariatric surgery patients
MIAMI — Solara Labs on Tuesday announced the launch of its BariMelts line of dietary supplements produced for bariatric surgery patients.
"The enhanced nutrient availability of BariMelts provides patients with a new option for getting the supplemental nutrition so important to their long-term success following bariatric surgery," said J. Rocca, CEO Solara Labs.
-
Aurobindo Pharma's ANDA of olanzapine orally disintegrating tablets approved
HYDERABAD, India — Aurobindo Pharma on May 15 gained approval to produce a generic version of olanzapine orally disintegrating tablets in 5-mg, 10-mg, 15-mg and 20-mg strengths. The drug is the generic version of Zyprexa Zydis tablets from Eli Lilly.
The drug is used for the treatment of schizophrenia or bipolar I disorder.
Olanzapine orally disintegrating tablets had U.S. sales of $120.8 million for the 12 months ended March 31, according to IMS Health.